fda on bpc 157 Exciting news for peptides coming out of today's committee hearing! The Pharmacy Compounding Advisory Committee voted 8-6 to recommend adding BPC- to the 503A Bulks List for use in compounding for Peptides in the Limelight: US

11 Original Roberts cytoprotection/adaptive cytoprotection/organoprotection concept elaborated with BPC 157 as prototype of cytoprotective agents/mediators Pleiotropic beneficial activity Unlike the standard agents (i.e., prostaglandins, somatostatin, sulfhydryls) (in)activity, 11 the stable gastric pentadecapeptide BPC 157 actually satisfies these full activity criteria completely

Tesamorelin & CJC-1295 (Mod GRF 1-29) & Ipamorelin Studies on Liver and Metabolic Markers Tesamorelin has been investigated in relation to hepatic lipid accumulation and liver fibrosis progression

it doesnt even require preparation or sedation

Our infrastructure encompasses modern quality inspection unit and commodious warehousing facility for hygienic and tamper proof packaging of medicines